On February 22, 2011, the Compensation Committee of the Board of Directors of Momenta Pharmaceuticals, Inc., a Delaware corporation (the “Company”), approved the following grants of options to purchase shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), and awards of restricted Common Stock relating to performance during the fiscal year ended December 31, 2010 for the executive officers of the Company listed below:
Stock Options Restricted Stock
Craig A. Wheeler
100,000 75,000
Richard P. Shea
23,178 9,271
James Roach
23,178 9,271
John E. Bishop
25,495 10,198
The stock option grants set forth above were made under the Company’s 2004 Stock Incentive Plan, as amended (the “2004 Stock Plan”), under the following terms: (i) an exercise price equal to the last reported sale price of the Common Stock on the date of grant, or $13.26 per share, (ii) a ten year duration and (iii) vesting quarterly over the four-year period following the date of grant, provided that the optionee has a continuous relationship with the Company. The shares of restricted Common Stock set forth above were also awarded under the 2004 Stock Plan. Twenty-five percent of the shares of restricted Common Stock subject to such awards shall vest on February 22, 2012 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter. The Company’s form of Incentive Stock Option Agreement was filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004 and is incorporated herein by reference. The Company’s form of Restricted Stock Agreement was filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on February 28, 2008 and is incorporated herein by reference.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.